quinuclidines has been researched along with Cognitive Decline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, NX; Yao, YT; Ying, H; Yuan, X; Zhang, YB | 1 |
| Beck, WD; Blake, DT; Callahan, PM; Plagenhoef, MR; Terry, AV | 1 |
| Ailing, Y; Hongyu, X; Liwu, Z; Qingting, W; Xiaoling, S; Xin, L | 1 |
| Compion, G; Dale, M; Stow, B; Tretter, R; Wagg, A | 2 |
| Wein, AJ | 1 |
| Bain, EE; Baker, JD; Haig, GM; Othman, AA; Robieson, WZ | 1 |
| Cornu, JN | 1 |
1 review(s) available for quinuclidines and Cognitive Decline
| Article | Year |
|---|---|
Penehyclidine Hydrochloride Premedication Is Not Associated with Increased Incidence of Post-Operative Cognitive Dysfunction or Delirium:A Systemic Review and Meta-Analysis.
Topics: Cognitive Dysfunction; Delirium; Humans; Incidence; Postoperative Complications; Quinuclidines | 2020 |
3 trial(s) available for quinuclidines and Cognitive Decline
| Article | Year |
|---|---|
Penehyclidine hydrochloride on postoperatively cognitive function.
Topics: Aged; Anesthesia, General; Atropine; Cholinergic Antagonists; Cognition; Cognitive Dysfunction; Cytokines; Delirium; Female; Humans; Incidence; Inflammation; Lung Neoplasms; Male; Mental Status and Dementia Tests; Postoperative Complications; Postoperative Period; Quinuclidines; Thoracoscopy; Treatment Outcome | 2019 |
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Attention; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychometrics; Quinuclidines; Schizophrenia; Schizophrenic Psychology; Smoking; Thiadiazoles; Treatment Outcome; Verbal Learning | 2016 |
Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Attention; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Mandelic Acids; Memory; Muscarinic Antagonists; Quinuclidines; Risk Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2013 |
4 other study(ies) available for quinuclidines and Cognitive Decline
| Article | Year |
|---|---|
Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing.
Topics: Aging; Animals; Cognition; Cognitive Dysfunction; Drug Evaluation, Preclinical; Female; Macaca mulatta; Male; Memory, Short-Term; Nootropic Agents; Quinuclidines; Thiophenes | 2021 |
Reply from authors re: Jean-Nicolas Cornu. Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg. Eur Urol 2013;64:82-3.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
Re: randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2014 |
Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |